Bismuth quadruple therapy to eradicate H. pylori :- Medznat
EN | RU
EN | RU

Help Support

Back

Influence of low-dose quadruple therapy with Bismuth or L. reuteri on gut microbiota

Bismuth quadruple therapy Bismuth quadruple therapy
Bismuth quadruple therapy Bismuth quadruple therapy

A single-centre, randomized controlled study aimed to examine the effects of low-dose quadruple treatment with Bismuth or Lactobacillus reuteri (L. reuteri) on the microbiota.

See All

Key take away

When used twice daily for 10 days, low-dose Bismuth quadruple treatment can effectively eradicate H. pylori infections with reduced costs, and minimized the amount of Bismuth and antibiotics.

Background

A single-centre, randomized controlled study aimed to examine the effects of low-dose quadruple treatment with Bismuth or Lactobacillus reuteri (L. reuteri) on the microbiota.

Method

Overall, 46 adult patients with Helicobacter pylori (H. pylori) infection were prospectively recruited. Participants received either low-dose quadruple therapy encompassing Bismuth and 20 mg Rabeprazole administered twice daily with meals for 10 days, or the same dose of Rabeprazole and antibiotics plus L. reuteri, one tablet two times a day for 27 days. Stool samples were gathered at the enrolment, at the ending, and 30-40 days post-therapy. Using 16S rRNA gene sequencing, the gut microbiota's composition was investigated.

Result

In both groups, the H. pylori elimination rate according to intention-to-treat (ITT) analysis and per protocol (PP) analysis is illustrated in Table 1:

At the end of therapy, alpha and beta diversity declined and was related to a decrease of bacterial genera useful for gut homeostasis. Both groups recovered after 30 to 40 days, indicating that the 2 regimens had a similar effect on the complexity of the bacterial community.

Conclusion

The use of low-dose Bismuth quadruple treatment was beneficial for H. pylori-infected patients. For subjects with contraindications to Bismuth, replacement of Bismuth with L. reuteri seems to be a promising option. However, L. reuteri was not able to substantially reverse antibiotics-triggered dysbiosis.

Source:

Nutrients

Article:

Metagenomic Changes of Gut Microbiota following Treatment of Helicobacter pylori Infection with a Simplified Low-Dose Quadruple Therapy with Bismuth or Lactobacillus reuteri

Authors:

Maria Pina Dore et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: